pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3937 |
Genomic Coordinates | chrX: 39661216 - 39661321 |
Description | Homo sapiens miR-3937 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3937 | |||||||||||||||||||||
Sequence | 61| ACAGGCGGCUGUAGCAAUGGGGG |83 | |||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||
Experiments | Illumina | |||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | NDUFA11 | ||||||||||||||||||||
Synonyms | B14.7, CI-B14.7 | ||||||||||||||||||||
Description | NADH:ubiquinone oxidoreductase subunit A11 | ||||||||||||||||||||
Transcript | NM_175614 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on NDUFA11 | |||||||||||||||||||||
3'UTR of NDUFA11 (miRNA target sites are highlighted) |
>NDUFA11|NM_175614|3'UTR 1 GCCCTGTGCCTGCCGGGACCTCCAGCCTGCAGAATGCGTCCAGAAATAAATTCTGTGTCTGTGTGTGTGTCAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | BC-3 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM796039. RNA binding protein: AGO2. Condition:4-Thiouridine
PAR-CLIP data was present in GSM796040. RNA binding protein: AGO2. Condition:4-Thiouridine
... - Gottwein E; Corcoran DL; Mukherjee N; et al., 2011, Cell host & microbe. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Gottwein E; Corcoran DL; Mukherjee N; et al. - Cell host & microbe, 2011
Primary effusion lymphoma (PEL) is caused by Kaposi's sarcoma-associated herpesvirus (KSHV) and frequently also harbors Epstein-Barr virus (EBV). The expression of KSHV- and EBV-encoded microRNAs (miRNAs) in PELs suggests a role for these miRNAs in latency and lymphomagenesis. Using PAR-CLIP, a technology which allows the direct and transcriptome-wide identification of miRNA targets, we delineate the target sites for all viral and cellular miRNAs expressed in PEL cell lines. The resulting data set revealed that KSHV miRNAs directly target more than 2000 cellular mRNAs, including many involved in pathways relevant to KSHV pathogenesis. Moreover, 58% of these mRNAs are also targeted by EBV miRNAs, via distinct binding sites. In addition to a known viral analog of cellular miR-155, we show that KSHV encodes a viral miRNA that mimics cellular miR-142-3p function. In summary, this study identifies an extensive list of KSHV miRNA targets, which are likely to influence viral replication and pathogenesis.
LinkOut: [PMID: 22100165]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | LCL-BAC |
Disease | MIMAT0018352 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1020023. RNA binding protein: AGO2. Condition:EBV B95-8-infected
... - Skalsky RL; Corcoran DL; Gottwein E; Frank et al., 2012, PLoS pathogens. |
Article |
- Skalsky RL; Corcoran DL; Gottwein E; Frank et al. - PLoS pathogens, 2012
Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus linked to a number of B cell cancers and lymphoproliferative disorders. During latent infection, EBV expresses 25 viral pre-microRNAs (miRNAs) and induces the expression of specific host miRNAs, such as miR-155 and miR-21, which potentially play a role in viral oncogenesis. To date, only a limited number of EBV miRNA targets have been identified; thus, the role of EBV miRNAs in viral pathogenesis and/or lymphomagenesis is not well defined. Here, we used photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP) combined with deep sequencing and computational analysis to comprehensively examine the viral and cellular miRNA targetome in EBV strain B95-8-infected lymphoblastoid cell lines (LCLs). We identified 7,827 miRNA-interaction sites in 3,492 cellular 3'UTRs. 531 of these sites contained seed matches to viral miRNAs. 24 PAR-CLIP-identified miRNA:3'UTR interactions were confirmed by reporter assays. Our results reveal that EBV miRNAs predominantly target cellular transcripts during latent infection, thereby manipulating the host environment. Furthermore, targets of EBV miRNAs are involved in multiple cellular processes that are directly relevant to viral infection, including innate immunity, cell survival, and cell proliferation. Finally, we present evidence that myc-regulated host miRNAs from the miR-17/92 cluster can regulate latent viral gene expression. This comprehensive survey of the miRNA targetome in EBV-infected B cells represents a key step towards defining the functions of EBV-encoded miRNAs, and potentially, identifying novel therapeutic targets for EBV-associated malignancies.
LinkOut: [PMID: 22291592]
|
CLIP-seq Support 1 for dataset GSM1020023 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | LCL-BAC / EBV B95-8-infected, 4-thiouridine, RNase T1 |
Location of target site | ENST00000592634.1 | 3UTR | uuggcgccgccgccug |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22291592 / GSE41437 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM796039 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | BC-3 / 4-Thiouridine |
Location of target site | ENST00000592634.1 | 3UTR | uuggcgccgccgccug |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22100165 / GSE32109 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM796040 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | BC-3 / 4-Thiouridine |
Location of target site | ENST00000592634.1 | 3UTR | uuggcgccgccgccugc |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22100165 / GSE32109 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
40 hsa-miR-3937 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT332487 | CD81 | CD81 molecule | 2 | 2 | ||||||||
MIRT441327 | NDUFA11 | NADH:ubiquinone oxidoreductase subunit A11 | 2 | 4 | ||||||||
MIRT454032 | EIF3CL | eukaryotic translation initiation factor 3 subunit C like | 2 | 2 | ||||||||
MIRT458086 | EIF3C | eukaryotic translation initiation factor 3 subunit C | 2 | 2 | ||||||||
MIRT460785 | VPS37B | VPS37B, ESCRT-I subunit | 2 | 2 | ||||||||
MIRT463150 | ZNF385A | zinc finger protein 385A | 2 | 4 | ||||||||
MIRT467162 | SREBF2 | sterol regulatory element binding transcription factor 2 | 2 | 2 | ||||||||
MIRT469618 | RAI1 | retinoic acid induced 1 | 2 | 4 | ||||||||
MIRT472258 | NFIC | nuclear factor I C | 2 | 2 | ||||||||
MIRT487587 | FAM83H | family with sequence similarity 83 member H | 2 | 4 | ||||||||
MIRT489302 | B4GALNT4 | beta-1,4-N-acetyl-galactosaminyltransferase 4 | 2 | 4 | ||||||||
MIRT489741 | GNAI2 | G protein subunit alpha i2 | 2 | 4 | ||||||||
MIRT490038 | PCSK4 | proprotein convertase subtilisin/kexin type 4 | 2 | 2 | ||||||||
MIRT490767 | SRCIN1 | SRC kinase signaling inhibitor 1 | 2 | 2 | ||||||||
MIRT491750 | SEMA3F | semaphorin 3F | 2 | 2 | ||||||||
MIRT492690 | PHYHIP | phytanoyl-CoA 2-hydroxylase interacting protein | 2 | 2 | ||||||||
MIRT504843 | RRP36 | ribosomal RNA processing 36 | 2 | 4 | ||||||||
MIRT510116 | IRAK3 | interleukin 1 receptor associated kinase 3 | 2 | 8 | ||||||||
MIRT525313 | FANCA | Fanconi anemia complementation group A | 2 | 4 | ||||||||
MIRT569801 | IGDCC3 | immunoglobulin superfamily DCC subclass member 3 | 2 | 2 | ||||||||
MIRT570224 | SLC27A1 | solute carrier family 27 member 1 | 2 | 2 | ||||||||
MIRT629378 | FAHD1 | fumarylacetoacetate hydrolase domain containing 1 | 2 | 2 | ||||||||
MIRT633104 | CBX5 | chromobox 5 | 2 | 2 | ||||||||
MIRT645036 | ATAD3C | ATPase family, AAA domain containing 3C | 2 | 2 | ||||||||
MIRT660973 | ABI2 | abl interactor 2 | 2 | 2 | ||||||||
MIRT671225 | CLSTN1 | calsyntenin 1 | 2 | 2 | ||||||||
MIRT672046 | SMTNL2 | smoothelin like 2 | 2 | 2 | ||||||||
MIRT677314 | CPSF2 | cleavage and polyadenylation specific factor 2 | 2 | 2 | ||||||||
MIRT678290 | PTRH2 | peptidyl-tRNA hydrolase 2 | 2 | 2 | ||||||||
MIRT693477 | ZNF707 | zinc finger protein 707 | 2 | 2 | ||||||||
MIRT693576 | PIGR | polymeric immunoglobulin receptor | 2 | 2 | ||||||||
MIRT696832 | PLLP | plasmolipin | 2 | 2 | ||||||||
MIRT700149 | RNF115 | ring finger protein 115 | 2 | 2 | ||||||||
MIRT703760 | FAM118A | family with sequence similarity 118 member A | 2 | 2 | ||||||||
MIRT705798 | ALDH6A1 | aldehyde dehydrogenase 6 family member A1 | 2 | 2 | ||||||||
MIRT709105 | SEPT4 | septin 4 | 2 | 2 | ||||||||
MIRT710235 | ARMCX6 | armadillo repeat containing, X-linked 6 | 2 | 2 | ||||||||
MIRT711422 | EPHA4 | EPH receptor A4 | 2 | 2 | ||||||||
MIRT712529 | CYTH2 | cytohesin 2 | 2 | 2 | ||||||||
MIRT714081 | ZNF532 | zinc finger protein 532 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|